SPHERA FUNDS MANAGEMENT LTD.'s Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:34PM EST
Who is SPHERA FUNDS MANAGEMENT LTD.?
SPHERA FUNDS MANAGEMENT LTD. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., NeurogesX Inc, Werewolf Therapeutics, Inc., and OREXIGEN THERAPEUTICS INC.
SEC CIK
SPHERA FUNDS MANAGEMENT LTD.'s CIK is 0001496201
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Orexigen Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.38% | -20.00K |
$4.15 | -$82,990.00 | 571.88K |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -163.47K |
$2.08 | -$339,745.13 |
0
|
Aug 9 - Aug 10
| |||
Form 4
| -4.99% | -8.58K |
$2.10 | -$18,023.80 | 163.47K |
Jun 24 - Jun 27
| |||
Form 4
| -22.52% | -50.00K |
$2.09 | -$104,535.00 | 172.05K |
Jun 23
| |||
Form 4/A
| -50.90% | -399.00K |
$3.03 | -$1,253,277.49 | 384.81K |
Jun 16
| |||
Form 4
| -50.90% | -399.00K |
$3.03 | -$1,253,277.49 | 384.81K |
Jun 16
| |||
Form 4
| -7.46% | -21.11K |
$2.35 | -$49,421.75 | 261.77K |
Jun 2 - Jun 3
| |||
Form 4
| -3.74% | -11.00K |
$2.46 | -$27,023.70 | 282.88K |
Jun 1
| |||
Form 4
| -4.02% | -12.32K |
$4.07 | -$50,137.21 | 293.88K |
Mar 28
| |||
Form 4
| -22.62% | -152.60K |
$4.03 | -$615,550.28 | 522.05K |
Mar 24
| |||
Form 4
| -3.33% | -33.80K |
$4.00 | -$135,434.38 | 980.84K |
Mar 23
| |||
Form 4
| -4.13% | -14.11K |
$3.67 | -$51,780.37 | 327.89K |
Feb 28 - Mar 1
| |||
Form 4
| +25.47% | 208.84K |
$8.00 | $1,622,381.20 | 1.03M |
Dec 3 - Jul 1
| |||
Form 4
| +99.06% | 408.03K |
$8.38 | $3,401,341.24 | 819.91K |
Sep 11 - Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $2.03
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 788K |
$16.00 |
—
| 788K |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OREXIGEN THERAPEUTICS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||